Stauffer F, Haber H, Rieger A, Mutschlechner R, Hasenberger P, Tevere V J, Young K K
Federal Public Health Laboratory, Vienna, Austria.
J Clin Microbiol. 1998 Mar;36(3):614-7. doi: 10.1128/JCM.36.3.614-617.1998.
An easy-to-handle Mycobacterium-specific PCR assay for detection of the presence of a wide range of mycobacterial species in clinical samples was evaluated. The performance of the genus probe was compared with the performance of probes specific for Mycobacterium tuberculosis and Mycobacterium avium and with that of standard culture. In addition, the utility of an internal control in monitoring amplification inhibitors was studied. Of 545 respiratory and 325 nonrespiratory specimens (a total of 870 specimens), 58 (6.7%) showed the presence of amplification inhibitors, as determined by a negative result for the internal control. Of these 58 specimens, 31 (53%) were stool specimens; other material, even citrate blood after lysis of erythrocytes, did not pose a problem with regard to inhibition of PCR amplification. Eighty-one of the remaining 812 specimens had a positive Mycobacterium culture result. Of these culture-positive specimens, 58 (71.6%) showed a positive result with the Mycobacterium genus-specific probe. Seventy-two samples had a positive result with the Mycobacterium-specific probe but a negative culture result. Of these 72 samples, 26 samples were regarded as true positive, either because the M. tuberculosis- or M. avium-specific probe was also positive at the same time or because other specimens from the same patient taken at the same time were culture positive. The sensitivity of the Mycobacterium-specific probe was 78.5% and the specificity was 93.5%. This study showed that pretesting of clinical specimens for mycobacteria to the genus level with a Mycobacterium-specific probe offers the routine clinical laboratory the possibility of detecting tuberculous and nontuberculous mycobacteria with one test. Furthermore, specimens testing positive with the genus-specific probe can be immediately identified with species-specific probes.
评估了一种易于操作的分枝杆菌特异性PCR检测方法,用于检测临床样本中多种分枝杆菌的存在情况。将属特异性探针的性能与结核分枝杆菌和鸟分枝杆菌特异性探针的性能以及标准培养法的性能进行了比较。此外,还研究了内部对照在监测扩增抑制剂方面的实用性。在545份呼吸道标本和325份非呼吸道标本(共870份标本)中,有58份(6.7%)显示存在扩增抑制剂,这是通过内部对照的阴性结果确定的。在这58份标本中,31份(53%)是粪便标本;其他材料,即使是红细胞裂解后的枸橼酸盐血,在PCR扩增抑制方面也没有问题。其余812份标本中有81份分枝杆菌培养结果为阳性。在这些培养阳性的标本中,58份(71.6%)用分枝杆菌属特异性探针检测结果为阳性。72份标本用分枝杆菌特异性探针检测结果为阳性,但培养结果为阴性。在这72份标本中,26份标本被视为真阳性,要么是因为结核分枝杆菌或鸟分枝杆菌特异性探针同时也为阳性,要么是因为同一患者同时采集的其他标本培养阳性。分枝杆菌特异性探针的敏感性为78.5%,特异性为93.5%。这项研究表明,用分枝杆菌特异性探针将临床标本进行分枝杆菌属水平的预检测,为常规临床实验室提供了通过一次检测检测结核分枝杆菌和非结核分枝杆菌的可能性。此外,用属特异性探针检测呈阳性的标本可以立即用种特异性探针进行鉴定。